 Tim Lahm
Concepts (458)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 52 | 2023 | 1736 | 9.450 |
Why?
| | Ventricular Dysfunction, Right | 21 | 2023 | 218 | 5.940 |
Why?
| | Ventricular Function, Right | 16 | 2023 | 252 | 3.090 |
Why?
| | Pulmonary Artery | 23 | 2023 | 1028 | 2.920 |
Why?
| | Estradiol | 8 | 2021 | 455 | 2.460 |
Why?
| | Hypoxia | 16 | 2023 | 958 | 2.270 |
Why?
| | Estrogens | 11 | 2023 | 313 | 2.100 |
Why?
| | Estrogen Receptor alpha | 5 | 2021 | 121 | 1.750 |
Why?
| | Hypertrophy, Right Ventricular | 9 | 2023 | 141 | 1.700 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 3 | 2021 | 48 | 1.560 |
Why?
| | Pulmonary Embolism | 4 | 2023 | 184 | 1.550 |
Why?
| | Estrogen Receptor beta | 3 | 2018 | 35 | 1.410 |
Why?
| | Familial Primary Pulmonary Hypertension | 10 | 2023 | 190 | 1.380 |
Why?
| | Vasoconstriction | 8 | 2008 | 186 | 1.370 |
Why?
| | Sex Characteristics | 10 | 2022 | 635 | 1.360 |
Why?
| | Rats, Sprague-Dawley | 28 | 2022 | 2212 | 1.250 |
Why?
| | Receptors, Estrogen | 4 | 2023 | 372 | 1.220 |
Why?
| | Gonadal Steroid Hormones | 7 | 2021 | 124 | 1.170 |
Why?
| | Nitric Oxide | 5 | 2021 | 827 | 1.160 |
Why?
| | Ventricular Function, Left | 5 | 2019 | 469 | 1.120 |
Why?
| | Apelin | 3 | 2021 | 8 | 1.030 |
Why?
| | Heart Failure | 8 | 2023 | 1962 | 1.030 |
Why?
| | Ventricular Remodeling | 6 | 2023 | 227 | 1.010 |
Why?
| | Rats | 27 | 2023 | 4973 | 0.980 |
Why?
| | Heart | 5 | 2020 | 610 | 0.970 |
Why?
| | Animals | 62 | 2023 | 31867 | 0.960 |
Why?
| | Endothelial Cells | 8 | 2023 | 685 | 0.950 |
Why?
| | Veterans | 6 | 2020 | 1238 | 0.790 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2018 | 249 | 0.780 |
Why?
| | Male | 57 | 2023 | 55730 | 0.780 |
Why?
| | Heart Ventricles | 8 | 2023 | 714 | 0.770 |
Why?
| | Humans | 77 | 2023 | 115039 | 0.760 |
Why?
| | Lung | 11 | 2023 | 3595 | 0.740 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2020 | 38 | 0.710 |
Why?
| | Ventricular Pressure | 7 | 2022 | 37 | 0.710 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2020 | 76 | 0.700 |
Why?
| | Renin-Angiotensin System | 1 | 2020 | 71 | 0.700 |
Why?
| | Stenosis, Pulmonary Artery | 1 | 2020 | 4 | 0.700 |
Why?
| | Iron | 2 | 2021 | 234 | 0.700 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 180 | 0.670 |
Why?
| | Lung Injury | 2 | 2015 | 198 | 0.650 |
Why?
| | Cardiovascular System | 1 | 2020 | 126 | 0.640 |
Why?
| | Pulmonary Wedge Pressure | 2 | 2020 | 63 | 0.630 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 1 | 2018 | 10 | 0.630 |
Why?
| | Disease Models, Animal | 16 | 2023 | 3545 | 0.620 |
Why?
| | Hepatopulmonary Syndrome | 1 | 2018 | 24 | 0.620 |
Why?
| | Histamine H2 Antagonists | 1 | 2018 | 29 | 0.610 |
Why?
| | Liver Diseases | 1 | 2021 | 259 | 0.610 |
Why?
| | Neovascularization, Pathologic | 2 | 2017 | 281 | 0.610 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2017 | 129 | 0.600 |
Why?
| | Bronchodilator Agents | 2 | 2017 | 243 | 0.580 |
Why?
| | Hyperoxia | 2 | 2015 | 99 | 0.570 |
Why?
| | Vascular Diseases | 1 | 2020 | 231 | 0.570 |
Why?
| | Up-Regulation | 4 | 2021 | 812 | 0.570 |
Why?
| | Myocardial Contraction | 3 | 2017 | 313 | 0.560 |
Why?
| | Intention | 1 | 2018 | 143 | 0.560 |
Why?
| | High-Intensity Interval Training | 1 | 2016 | 18 | 0.550 |
Why?
| | Vascular Endothelial Growth Factor A | 10 | 2023 | 499 | 0.540 |
Why?
| | Female | 43 | 2023 | 59611 | 0.530 |
Why?
| | Reperfusion Injury | 4 | 2011 | 254 | 0.510 |
Why?
| | Research | 1 | 2018 | 395 | 0.490 |
Why?
| | Cell Hypoxia | 7 | 2018 | 220 | 0.490 |
Why?
| | Sex Factors | 9 | 2021 | 1721 | 0.470 |
Why?
| | Hemodynamics | 7 | 2022 | 1017 | 0.450 |
Why?
| | Blood Pressure | 4 | 2015 | 1539 | 0.450 |
Why?
| | Vascular Remodeling | 5 | 2020 | 153 | 0.440 |
Why?
| | Hypertension | 2 | 2021 | 1058 | 0.430 |
Why?
| | Signal Transduction | 9 | 2020 | 4525 | 0.390 |
Why?
| | Cardiac Resynchronization Therapy | 1 | 2012 | 42 | 0.390 |
Why?
| | Whipple Disease | 1 | 2011 | 5 | 0.390 |
Why?
| | Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2011 | 19 | 0.390 |
Why?
| | Embolism, Air | 1 | 2011 | 11 | 0.390 |
Why?
| | Magnesium Sulfate | 1 | 2011 | 17 | 0.380 |
Why?
| | Adaptation, Physiological | 3 | 2020 | 481 | 0.380 |
Why?
| | Pneumothorax | 1 | 2011 | 41 | 0.370 |
Why?
| | Calcium Channel Blockers | 1 | 2011 | 115 | 0.370 |
Why?
| | Leukapheresis | 1 | 2010 | 25 | 0.360 |
Why?
| | Bradykinin | 1 | 2010 | 43 | 0.350 |
Why?
| | Aged | 14 | 2021 | 19119 | 0.350 |
Why?
| | Pulmonary Circulation | 3 | 2023 | 407 | 0.350 |
Why?
| | Sepsis | 3 | 2010 | 508 | 0.350 |
Why?
| | Paracrine Communication | 6 | 2008 | 56 | 0.330 |
Why?
| | Leukocytes | 1 | 2010 | 277 | 0.330 |
Why?
| | Calcium | 2 | 2012 | 1104 | 0.320 |
Why?
| | Myocardium | 5 | 2020 | 922 | 0.320 |
Why?
| | Middle Aged | 15 | 2021 | 26827 | 0.310 |
Why?
| | Blastomycosis | 1 | 2008 | 8 | 0.310 |
Why?
| | Acute Lung Injury | 1 | 2011 | 300 | 0.300 |
Why?
| | Stroke Volume | 3 | 2020 | 510 | 0.290 |
Why?
| | Adult | 14 | 2021 | 30655 | 0.290 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2007 | 73 | 0.280 |
Why?
| | Endothelins | 1 | 2007 | 61 | 0.280 |
Why?
| | Lung Diseases | 3 | 2022 | 703 | 0.280 |
Why?
| | Menstrual Cycle | 1 | 2007 | 108 | 0.270 |
Why?
| | Cardiotonic Agents | 2 | 2021 | 119 | 0.270 |
Why?
| | Neoplasms | 1 | 2020 | 2106 | 0.270 |
Why?
| | Vascular Resistance | 2 | 2020 | 337 | 0.270 |
Why?
| | Administration, Inhalation | 2 | 2019 | 641 | 0.270 |
Why?
| | Monocrotaline | 3 | 2022 | 33 | 0.260 |
Why?
| | Calcium Signaling | 1 | 2007 | 213 | 0.250 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 499 | 0.240 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2007 | 386 | 0.240 |
Why?
| | Myocardial Reperfusion Injury | 3 | 2010 | 91 | 0.240 |
Why?
| | Antihypertensive Agents | 2 | 2018 | 430 | 0.240 |
Why?
| | Rats, Mutant Strains | 2 | 2021 | 25 | 0.240 |
Why?
| | Databases, Factual | 2 | 2020 | 1132 | 0.240 |
Why?
| | Propionates | 2 | 2018 | 34 | 0.230 |
Why?
| | Autophagy | 2 | 2016 | 234 | 0.220 |
Why?
| | Physical Conditioning, Animal | 2 | 2016 | 196 | 0.220 |
Why?
| | Reproductive Health Services | 1 | 2023 | 9 | 0.220 |
Why?
| | Double-Blind Method | 2 | 2019 | 1664 | 0.220 |
Why?
| | Nitriles | 2 | 2018 | 152 | 0.220 |
Why?
| | Aged, 80 and over | 7 | 2021 | 6357 | 0.220 |
Why?
| | Myocytes, Cardiac | 3 | 2021 | 448 | 0.220 |
Why?
| | United States Department of Veterans Affairs | 2 | 2017 | 557 | 0.220 |
Why?
| | SOXF Transcription Factors | 2 | 2023 | 18 | 0.220 |
Why?
| | United States | 11 | 2022 | 12224 | 0.220 |
Why?
| | Echocardiography | 2 | 2017 | 557 | 0.210 |
Why?
| | Stem Cell Transplantation | 3 | 2008 | 149 | 0.210 |
Why?
| | Chloride Channels | 1 | 2023 | 35 | 0.210 |
Why?
| | Lung Neoplasms | 2 | 2014 | 2201 | 0.210 |
Why?
| | Mice | 13 | 2023 | 14927 | 0.210 |
Why?
| | Chlorides | 1 | 2023 | 127 | 0.200 |
Why?
| | Intercellular Signaling Peptides and Proteins | 3 | 2015 | 349 | 0.190 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2021 | 45 | 0.190 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2022 | 144 | 0.190 |
Why?
| | Menopause, Premature | 1 | 2021 | 8 | 0.190 |
Why?
| | Young Adult | 8 | 2021 | 10498 | 0.190 |
Why?
| | Atrial Pressure | 1 | 2020 | 4 | 0.180 |
Why?
| | Cytokines | 5 | 2015 | 1843 | 0.180 |
Why?
| | Metabolic Diseases | 1 | 2021 | 98 | 0.180 |
Why?
| | Testosterone | 4 | 2014 | 343 | 0.180 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1398 | 0.180 |
Why?
| | Phenylephrine | 3 | 2008 | 74 | 0.180 |
Why?
| | Mice, Knockout | 4 | 2021 | 2585 | 0.180 |
Why?
| | Vasodilator Agents | 2 | 2013 | 307 | 0.180 |
Why?
| | Receptors, Androgen | 1 | 2021 | 131 | 0.180 |
Why?
| | Body Weight | 2 | 2015 | 873 | 0.180 |
Why?
| | Hormones | 1 | 2021 | 132 | 0.170 |
Why?
| | Ovariectomy | 4 | 2015 | 117 | 0.170 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 192 | 0.170 |
Why?
| | Models, Cardiovascular | 1 | 2021 | 179 | 0.170 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 4 | 2022 | 94 | 0.170 |
Why?
| | Vasoconstrictor Agents | 3 | 2008 | 112 | 0.170 |
Why?
| | Drugs, Investigational | 1 | 2019 | 30 | 0.170 |
Why?
| | Organ Size | 1 | 2020 | 444 | 0.170 |
Why?
| | Mesenchymal Stem Cell Transplantation | 3 | 2008 | 37 | 0.170 |
Why?
| | Propensity Score | 1 | 2020 | 224 | 0.170 |
Why?
| | Cardiac Catheterization | 2 | 2020 | 535 | 0.160 |
Why?
| | Respiratory Mucosa | 1 | 2021 | 251 | 0.160 |
Why?
| | Gender Identity | 1 | 2019 | 101 | 0.160 |
Why?
| | HLA-DP alpha-Chains | 1 | 2018 | 4 | 0.160 |
Why?
| | Y Chromosome | 1 | 2018 | 6 | 0.160 |
Why?
| | Lipopolysaccharides | 4 | 2010 | 817 | 0.160 |
Why?
| | Animals, Newborn | 4 | 2015 | 778 | 0.160 |
Why?
| | RNA, Messenger | 4 | 2021 | 2563 | 0.160 |
Why?
| | RNA, Long Noncoding | 1 | 2021 | 155 | 0.160 |
Why?
| | Metabolome | 1 | 2021 | 285 | 0.160 |
Why?
| | Troponin T | 1 | 2019 | 49 | 0.160 |
Why?
| | Arterial Pressure | 2 | 2016 | 99 | 0.160 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2018 | 26 | 0.160 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2016 | 184 | 0.160 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2018 | 20 | 0.160 |
Why?
| | HLA-DP beta-Chains | 1 | 2018 | 76 | 0.160 |
Why?
| | Adult Stem Cells | 2 | 2008 | 32 | 0.160 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2018 | 22 | 0.150 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2017 | 262 | 0.150 |
Why?
| | Risk Assessment | 4 | 2023 | 2976 | 0.150 |
Why?
| | Isolated Heart Preparation | 1 | 2017 | 2 | 0.150 |
Why?
| | Protein Stability | 1 | 2018 | 157 | 0.150 |
Why?
| | bcl-2-Associated X Protein | 1 | 2017 | 45 | 0.150 |
Why?
| | Cardiac Output | 3 | 2015 | 143 | 0.150 |
Why?
| | Societies, Medical | 2 | 2018 | 678 | 0.150 |
Why?
| | Cells, Cultured | 6 | 2018 | 3896 | 0.150 |
Why?
| | Dietary Supplements | 1 | 2021 | 458 | 0.150 |
Why?
| | Diastole | 1 | 2017 | 131 | 0.140 |
Why?
| | Myocardial Infarction | 2 | 2019 | 930 | 0.140 |
Why?
| | Bronchoscopy | 3 | 2021 | 244 | 0.140 |
Why?
| | Health Services Accessibility | 1 | 2023 | 765 | 0.140 |
Why?
| | Peptide Fragments | 2 | 2019 | 668 | 0.140 |
Why?
| | CD55 Antigens | 1 | 2016 | 27 | 0.140 |
Why?
| | Biomedical Research | 1 | 2022 | 585 | 0.140 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 99 | 0.140 |
Why?
| | Pyrroles | 1 | 2017 | 181 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 213 | 0.140 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 225 | 0.140 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 324 | 0.130 |
Why?
| | Altitude | 1 | 2020 | 434 | 0.130 |
Why?
| | Women's Health | 1 | 2018 | 271 | 0.130 |
Why?
| | Personnel Selection | 1 | 2017 | 63 | 0.130 |
Why?
| | Pulmonary Medicine | 1 | 2017 | 87 | 0.130 |
Why?
| | Dyspnea | 1 | 2017 | 218 | 0.130 |
Why?
| | Epithelium | 1 | 2016 | 297 | 0.130 |
Why?
| | Genetic Testing | 1 | 2018 | 380 | 0.130 |
Why?
| | Macrophages | 1 | 2022 | 1267 | 0.130 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2019 | 361 | 0.130 |
Why?
| | Research Report | 1 | 2016 | 75 | 0.130 |
Why?
| | Physical Endurance | 1 | 2016 | 231 | 0.130 |
Why?
| | Stem Cells | 3 | 2008 | 546 | 0.130 |
Why?
| | Biological Assay | 1 | 2016 | 113 | 0.130 |
Why?
| | Indoles | 1 | 2017 | 304 | 0.130 |
Why?
| | Melanocytes | 1 | 2015 | 55 | 0.130 |
Why?
| | Sleep Wake Disorders | 1 | 2018 | 232 | 0.130 |
Why?
| | Golgi Apparatus | 1 | 2015 | 89 | 0.130 |
Why?
| | Telemetry | 1 | 2015 | 35 | 0.120 |
Why?
| | Physical Exertion | 1 | 2016 | 211 | 0.120 |
Why?
| | Treatment Outcome | 3 | 2016 | 9122 | 0.120 |
Why?
| | Transcriptome | 1 | 2020 | 725 | 0.120 |
Why?
| | Pulmonary Blastoma | 1 | 2014 | 8 | 0.120 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 61 | 0.120 |
Why?
| | Models, Biological | 6 | 2021 | 1636 | 0.120 |
Why?
| | Health Policy | 1 | 2017 | 333 | 0.120 |
Why?
| | Chest Pain | 1 | 2014 | 81 | 0.120 |
Why?
| | Familial Hypophosphatemic Rickets | 1 | 2014 | 4 | 0.120 |
Why?
| | Fellowships and Scholarships | 1 | 2017 | 227 | 0.120 |
Why?
| | Dehydroepiandrosterone | 1 | 2014 | 49 | 0.110 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1127 | 0.110 |
Why?
| | Apoptosis | 2 | 2015 | 2366 | 0.110 |
Why?
| | Precision Medicine | 1 | 2017 | 340 | 0.110 |
Why?
| | Splenectomy | 1 | 2013 | 53 | 0.110 |
Why?
| | Oxygen Consumption | 1 | 2016 | 588 | 0.110 |
Why?
| | Oxygen | 2 | 2015 | 855 | 0.110 |
Why?
| | Ovary | 1 | 2015 | 191 | 0.110 |
Why?
| | World Health Organization | 1 | 2013 | 103 | 0.110 |
Why?
| | Fever | 1 | 2014 | 280 | 0.110 |
Why?
| | Length of Stay | 1 | 2017 | 950 | 0.110 |
Why?
| | Diagnosis, Differential | 2 | 2014 | 1355 | 0.110 |
Why?
| | Phosphates | 1 | 2014 | 159 | 0.110 |
Why?
| | Pulmonary Alveoli | 1 | 2015 | 374 | 0.110 |
Why?
| | Pulmonary Veins | 1 | 2014 | 85 | 0.110 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2015 | 220 | 0.110 |
Why?
| | Mice, Inbred C57BL | 8 | 2019 | 4718 | 0.110 |
Why?
| | Ischemia | 3 | 2015 | 363 | 0.110 |
Why?
| | Fibroblast Growth Factors | 1 | 2014 | 162 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2011 | 1857 | 0.100 |
Why?
| | Myocardial Ischemia | 3 | 2008 | 236 | 0.100 |
Why?
| | ROC Curve | 1 | 2014 | 447 | 0.100 |
Why?
| | Healthcare Disparities | 1 | 2017 | 480 | 0.100 |
Why?
| | Retrospective Studies | 4 | 2017 | 12547 | 0.100 |
Why?
| | Estrogen Antagonists | 1 | 2012 | 39 | 0.100 |
Why?
| | Mutation, Missense | 1 | 2014 | 296 | 0.100 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 69 | 0.100 |
Why?
| | Heart Arrest | 1 | 2015 | 289 | 0.100 |
Why?
| | Airway Remodeling | 1 | 2012 | 57 | 0.100 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2011 | 36 | 0.100 |
Why?
| | Exercise Therapy | 1 | 2015 | 351 | 0.100 |
Why?
| | Models, Animal | 2 | 2010 | 348 | 0.100 |
Why?
| | Asthma | 2 | 2021 | 2051 | 0.090 |
Why?
| | Oxidoreductases | 1 | 2011 | 92 | 0.090 |
Why?
| | Ceramides | 1 | 2011 | 94 | 0.090 |
Why?
| | Endothelium, Vascular | 2 | 2007 | 850 | 0.090 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2008 | 1138 | 0.090 |
Why?
| | Acute Disease | 2 | 2010 | 915 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 1729 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2015 | 1144 | 0.090 |
Why?
| | Immunomodulation | 1 | 2010 | 84 | 0.090 |
Why?
| | Prognosis | 1 | 2017 | 3334 | 0.090 |
Why?
| | Propofol | 1 | 2009 | 43 | 0.080 |
Why?
| | Angiopoietin-1 | 1 | 2009 | 10 | 0.080 |
Why?
| | Coronary Artery Bypass | 1 | 2010 | 196 | 0.080 |
Why?
| | Immune System | 1 | 2010 | 172 | 0.080 |
Why?
| | Acute Kidney Injury | 1 | 2015 | 638 | 0.080 |
Why?
| | Rabbits | 1 | 2010 | 750 | 0.080 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2008 | 38 | 0.080 |
Why?
| | Radiography | 1 | 2011 | 827 | 0.080 |
Why?
| | Hypnotics and Sedatives | 1 | 2009 | 134 | 0.080 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2008 | 25 | 0.080 |
Why?
| | Colorado | 1 | 2018 | 4089 | 0.080 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2008 | 33 | 0.080 |
Why?
| | Vasodilation | 1 | 2011 | 417 | 0.080 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 72 | 0.080 |
Why?
| | Anesthesia | 1 | 2009 | 118 | 0.080 |
Why?
| | Phenols | 1 | 2008 | 82 | 0.080 |
Why?
| | Positive-Pressure Respiration | 1 | 2008 | 68 | 0.070 |
Why?
| | Pluripotent Stem Cells | 1 | 2008 | 63 | 0.070 |
Why?
| | Embryonic Stem Cells | 1 | 2008 | 105 | 0.070 |
Why?
| | Nurses | 1 | 2009 | 144 | 0.070 |
Why?
| | Internship and Residency | 1 | 2017 | 941 | 0.070 |
Why?
| | Ventricular Function | 1 | 2007 | 56 | 0.070 |
Why?
| | Steroids | 1 | 2008 | 147 | 0.070 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 144 | 0.070 |
Why?
| | Pyruvates | 1 | 2007 | 20 | 0.070 |
Why?
| | Fibrosis | 2 | 2020 | 454 | 0.070 |
Why?
| | Antifungal Agents | 1 | 2008 | 129 | 0.070 |
Why?
| | Education | 2 | 2018 | 95 | 0.070 |
Why?
| | Dihydrotestosterone | 1 | 2007 | 39 | 0.070 |
Why?
| | Carbon Dioxide | 1 | 2008 | 218 | 0.070 |
Why?
| | Deferoxamine | 1 | 2007 | 18 | 0.070 |
Why?
| | Hospitalization | 1 | 2016 | 1754 | 0.070 |
Why?
| | Iron Chelating Agents | 1 | 2007 | 16 | 0.070 |
Why?
| | Bone Marrow Transplantation | 1 | 2008 | 241 | 0.070 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2007 | 48 | 0.070 |
Why?
| | Epithelial Cells | 2 | 2016 | 956 | 0.070 |
Why?
| | Homeostasis | 1 | 2010 | 578 | 0.070 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2009 | 294 | 0.070 |
Why?
| | Gastrointestinal Diseases | 1 | 2008 | 182 | 0.070 |
Why?
| | Inflammation | 2 | 2015 | 2485 | 0.070 |
Why?
| | rho-Associated Kinases | 1 | 2007 | 80 | 0.070 |
Why?
| | Interleukin-6 | 2 | 2008 | 676 | 0.070 |
Why?
| | Amino Acids, Dicarboxylic | 2 | 2016 | 11 | 0.070 |
Why?
| | Body Mass Index | 1 | 2014 | 1967 | 0.070 |
Why?
| | Prospective Studies | 1 | 2017 | 6232 | 0.070 |
Why?
| | Emphysema | 1 | 2007 | 110 | 0.070 |
Why?
| | Risk Factors | 2 | 2021 | 8642 | 0.060 |
Why?
| | Androgens | 1 | 2007 | 167 | 0.060 |
Why?
| | Coronary Disease | 1 | 2008 | 347 | 0.060 |
Why?
| | Endothelin-1 | 1 | 2007 | 167 | 0.060 |
Why?
| | Gene Expression | 2 | 2021 | 1423 | 0.060 |
Why?
| | Pyrazoles | 1 | 2008 | 362 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2008 | 476 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 752 | 0.060 |
Why?
| | MAP Kinase Signaling System | 1 | 2007 | 276 | 0.060 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2007 | 417 | 0.060 |
Why?
| | NF-kappa B | 1 | 2008 | 637 | 0.060 |
Why?
| | Embolectomy | 1 | 2023 | 11 | 0.060 |
Why?
| | Anti-Inflammatory Agents | 1 | 2007 | 451 | 0.060 |
Why?
| | Genetic Variation | 2 | 2018 | 876 | 0.060 |
Why?
| | Orchiectomy | 3 | 2008 | 57 | 0.060 |
Why?
| | HMGB Proteins | 1 | 2023 | 15 | 0.050 |
Why?
| | Thrombolytic Therapy | 1 | 2023 | 117 | 0.050 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2007 | 330 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2017 | 5040 | 0.050 |
Why?
| | Thorax | 1 | 2022 | 41 | 0.050 |
Why?
| | Lactates | 1 | 2022 | 84 | 0.050 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 97 | 0.050 |
Why?
| | Intestinal Mucosa | 1 | 2007 | 528 | 0.050 |
Why?
| | Aging | 2 | 2008 | 1624 | 0.050 |
Why?
| | Breath Tests | 1 | 2021 | 83 | 0.050 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2021 | 157 | 0.050 |
Why?
| | Rats, Wistar | 1 | 2022 | 369 | 0.050 |
Why?
| | Fibrillar Collagens | 1 | 2020 | 12 | 0.050 |
Why?
| | Kallikreins | 1 | 2020 | 30 | 0.050 |
Why?
| | Vital Capacity | 1 | 2021 | 257 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2020 | 47 | 0.050 |
Why?
| | Incidental Findings | 1 | 2021 | 76 | 0.050 |
Why?
| | Lab-On-A-Chip Devices | 1 | 2020 | 30 | 0.040 |
Why?
| | United Kingdom | 1 | 2021 | 227 | 0.040 |
Why?
| | Mitochondria, Heart | 1 | 2020 | 73 | 0.040 |
Why?
| | Exercise Test | 1 | 2023 | 545 | 0.040 |
Why?
| | Cattle | 1 | 2023 | 924 | 0.040 |
Why?
| | Down-Regulation | 2 | 2016 | 599 | 0.040 |
Why?
| | Biological Specimen Banks | 1 | 2021 | 94 | 0.040 |
Why?
| | Enzyme Activation | 2 | 2015 | 791 | 0.040 |
Why?
| | Kinetics | 2 | 2015 | 1558 | 0.040 |
Why?
| | Muscle, Skeletal | 2 | 2022 | 1477 | 0.040 |
Why?
| | Forced Expiratory Volume | 1 | 2021 | 476 | 0.040 |
Why?
| | Ligands | 1 | 2021 | 565 | 0.040 |
Why?
| | Critical Care | 1 | 2023 | 475 | 0.040 |
Why?
| | NAD | 1 | 2020 | 64 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2023 | 618 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 4904 | 0.040 |
Why?
| | Genotyping Techniques | 1 | 2018 | 69 | 0.040 |
Why?
| | Cell Shape | 2 | 2008 | 54 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2007 | 2329 | 0.040 |
Why?
| | Behavior | 1 | 2018 | 91 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2018 | 106 | 0.040 |
Why?
| | RNA, Small Interfering | 2 | 2011 | 541 | 0.040 |
Why?
| | Hepatocyte Growth Factor | 2 | 2008 | 33 | 0.040 |
Why?
| | Sleep Apnea Syndromes | 1 | 2018 | 74 | 0.040 |
Why?
| | Job Application | 1 | 2017 | 10 | 0.040 |
Why?
| | Adolescent | 4 | 2021 | 17862 | 0.040 |
Why?
| | Proteomics | 1 | 2023 | 844 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 675 | 0.040 |
Why?
| | Comprehension | 1 | 2018 | 155 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2015 | 2715 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2018 | 198 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 157 | 0.030 |
Why?
| | Gene Silencing | 1 | 2016 | 172 | 0.030 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2008 | 286 | 0.030 |
Why?
| | Prolyl Hydroxylases | 1 | 2015 | 4 | 0.030 |
Why?
| | Prolyl-Hydroxylase Inhibitors | 1 | 2015 | 4 | 0.030 |
Why?
| | Cyclopentanes | 1 | 2015 | 15 | 0.030 |
Why?
| | Blood Urea Nitrogen | 1 | 2015 | 51 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2015 | 117 | 0.030 |
Why?
| | Renal Circulation | 1 | 2015 | 53 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1211 | 0.030 |
Why?
| | Chloroquine | 1 | 2015 | 52 | 0.030 |
Why?
| | Age Factors | 2 | 2015 | 2894 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 797 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2015 | 134 | 0.030 |
Why?
| | Lysosomes | 1 | 2015 | 123 | 0.030 |
Why?
| | Proteolysis | 1 | 2015 | 143 | 0.030 |
Why?
| | Disease Management | 1 | 2018 | 563 | 0.030 |
Why?
| | Steroid Hydroxylases | 1 | 2014 | 19 | 0.030 |
Why?
| | Vitamin D3 24-Hydroxylase | 1 | 2014 | 14 | 0.030 |
Why?
| | Protein Folding | 1 | 2015 | 239 | 0.030 |
Why?
| | Protein Transport | 1 | 2015 | 398 | 0.030 |
Why?
| | Glycolysis | 1 | 2015 | 227 | 0.030 |
Why?
| | Complement Activation | 1 | 2016 | 340 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2014 | 46 | 0.030 |
Why?
| | Mortality | 1 | 2016 | 287 | 0.030 |
Why?
| | Creatinine | 1 | 2015 | 425 | 0.030 |
Why?
| | Calcitriol | 1 | 2014 | 53 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 2014 | 163 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2014 | 272 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2015 | 234 | 0.030 |
Why?
| | Phosphorylation | 2 | 2008 | 1572 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2014 | 262 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2015 | 556 | 0.030 |
Why?
| | Pyrimidines | 1 | 2015 | 375 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2018 | 1203 | 0.030 |
Why?
| | Research Design | 1 | 2017 | 930 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 2 | 2008 | 786 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 880 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2018 | 1901 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 928 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2551 | 0.020 |
Why?
| | Infant | 2 | 2017 | 7945 | 0.020 |
Why?
| | Quality of Life | 1 | 2021 | 2359 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 2815 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2108 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1812 | 0.020 |
Why?
| | Biosensing Techniques | 1 | 2011 | 99 | 0.020 |
Why?
| | Child, Preschool | 2 | 2017 | 9093 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 3350 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1317 | 0.020 |
Why?
| | Short Bowel Syndrome | 1 | 2008 | 19 | 0.020 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2008 | 26 | 0.020 |
Why?
| | Propanolamines | 1 | 2009 | 94 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2011 | 634 | 0.020 |
Why?
| | Organ Specificity | 1 | 2008 | 270 | 0.020 |
Why?
| | Endotoxins | 1 | 2009 | 205 | 0.020 |
Why?
| | Stromal Cells | 1 | 2008 | 96 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2008 | 68 | 0.020 |
Why?
| | Neovascularization, Physiologic | 1 | 2009 | 173 | 0.020 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2008 | 83 | 0.020 |
Why?
| | Osteoblasts | 1 | 2008 | 106 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2007 | 105 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 2007 | 141 | 0.020 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2007 | 23 | 0.020 |
Why?
| | Femur | 1 | 2008 | 193 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2009 | 746 | 0.020 |
Why?
| | Cell Lineage | 1 | 2008 | 310 | 0.020 |
Why?
| | Adipocytes | 1 | 2008 | 189 | 0.020 |
Why?
| | Diet | 1 | 2014 | 1076 | 0.020 |
Why?
| | RNA Interference | 1 | 2008 | 437 | 0.020 |
Why?
| | Tibia | 1 | 2008 | 168 | 0.020 |
Why?
| | Administration, Oral | 1 | 2009 | 730 | 0.020 |
Why?
| | Transfection | 1 | 2008 | 872 | 0.020 |
Why?
| | Thoracic Surgery | 1 | 2007 | 105 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2008 | 1036 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2341 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2008 | 1229 | 0.020 |
Why?
| | Child | 2 | 2017 | 18407 | 0.020 |
Why?
| | Tissue Engineering | 1 | 2008 | 366 | 0.010 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2008 | 288 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2011 | 2191 | 0.010 |
Why?
| | Heart Diseases | 1 | 2007 | 330 | 0.010 |
Why?
| | Blotting, Western | 1 | 2007 | 1149 | 0.010 |
Why?
| | Glucose | 1 | 2009 | 900 | 0.010 |
Why?
| | Fibroblasts | 1 | 2008 | 839 | 0.010 |
Why?
| | Interleukin-1 | 1 | 2007 | 970 | 0.010 |
Why?
| | Fetus | 1 | 2007 | 702 | 0.010 |
Why?
| | Pregnancy | 1 | 2014 | 5519 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2008 | 1700 | 0.010 |
Why?
| | Cell Line | 1 | 2007 | 2645 | 0.010 |
Why?
| | Neurons | 1 | 2008 | 1284 | 0.010 |
Why?
| | Time Factors | 1 | 2008 | 6141 | 0.010 |
Why?
|
|
Lahm's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|